Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa.
Lynch
Donna-Marie
DM
Slaven
Tracey
T
D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006295:Health Resources / Q000706:statistics & numerical data*; D006397:Hematinics / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins; D012107:Research Design; D013997:Time Factors; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa
Clin Drug Investig. 2006;26(10):593-601
17163293
Curr Med Res Opin. 2007 Jan;23(1):85-92
17257469